Modified Oral Rapid Drug Desensitization (ORDD) to Ibrutinib in a Patient with Stage IV Mantle Cell Lymphoma and Early Onset Grade 1 Hypersensitivity Reaction
- Resource Type
- Abstract
- Source
- In
The Journal of Allergy and Clinical Immunology February 2017 139(2) Supplement:AB38-AB38 - Subject
- Language
- ISSN
- 0091-6749